F Hoffmann La Roche Ag

USPTO Trademark & Patent Filings

F Hoffmann La Roche Ag

Trademark applications and grants for F Hoffmann La Roche Ag. F Hoffmann La Roche Ag has 3 trademark applications. The latest application filed is for "FLUZA"

Company Profile
    Company Aliases
  • F. Hoffmann-La Roche AG
  • ag roche la hoffmann f
  • F. HOFFMANN-LA ROCHE AG - Basel CH
  • F. Hoffmann-La Roche AG - Basel CH

Trademarks Patents
Patent Applications
Patent ApplicationDate
Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists
20220241260 - 17/083386 Chatterji; Ashish ;   et al.
2022-08-04
TAU ANTISENSE OLIGOMERS AND USES THEREOF
20220143064 - 17/367242 Olson; Richard E. ;   et al.
2022-05-12
ANTISENSE OLIGONUCLEOTIDES FOR MODULATING HTRA1 EXPRESSION
20220042022 - 17/404989 Sanchez; Ruben Alvarez ;   et al.
2022-02-10
TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF IN A SUBJECT HAVING INFLUENZA AND A SEVERE INFLUENZA CONDITION
20220008429 - 16/825263 UEHARA; Takeki ;   et al.
2022-01-13
Tetrahydro-1H-pyrazino[2,1-a]isoindolylquinoline Compounds for the Treatment of Autoimmune Disease
20210371432 - 16/972556 DEY; FABIAN ;   et al.
2021-12-02
Methods of using a bispecific antibody that recognizes coagulation factor IX and/or activated coagulation factor IX and coagulation factor X and/or activated coagulation factor X
11,352,438 - 16/330,269 Yoneyama , et al. June 7, 2
2022-06-07
Methods of using a bispecific antibody that recognizes coagulation factor IX and/or activated coagulation factor IX and coagulation factor X and/or activated coagulation factor X
11,352,438 - 16/330,269 Yoneyama , et al. June 7, 2
2022-06-07
Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
11,124,563 - 16/700,788 Lafaye , et al. September 21, 2
2021-09-21
Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
11,124,563 - 16/700,788 Lafaye , et al. September 21, 2
2021-09-21
Modified site-directed modifying polypeptides and methods of use thereof
11,118,194 - 16/061,291 Doudna , et al. September 14, 2
2021-09-14
Patent Grants & Applications

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed